|Articles|June 1, 2002

CME: C-reactive protein and ESR: What can one tell you that the other can't?

Although ESR is the more widely used test, most data suggest CRP is actually the more valuable of the two in the diagnosis and management of many inflammatory conditions.

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Subscribe Now!

Latest CME

Video

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Tina Bhutani, MD

Video

Cases and Conversations™: A Horizon View of Continuous Monitoring Systems for Diabetes Management

Diana Isaacs, PharmD, BCPS, BC-ADM, BCACP, CDCES, FADCES, FCCP; Anders Carlson, MD; Jennifer B. Green, MD

CME: C-reactive protein and ESR: What can one tell you that the other can't?

Newsletter

Related Content

Special Report: Expanding epinephrine options to reduce barriers, improve early use

Special Report: Recognizing, managing anaphylaxis in infants

Special Report: Delinking epinephrine use from mandatory ED visits

Special Report: Updated anaphylaxis guidelines, early management priorities

Routine car seat screening shows no clear benefit for infants

Latest CME

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Cases and Conversations™: A Horizon View of Continuous Monitoring Systems for Diabetes Management

Trending on Contemporary Pediatrics

Which children are most at risk for food allergy? New meta-analysis offers answers

Matthew Neidell, PhD, discusses community water fluoridation and birth outcomes

Switching from dupilumab to upadacitinib improves skin clearance, itch in atopic dermatitis

FDA issues CRL for RGX-121 gene therapy in mucopolysaccharidosis type II

Rezpegaldesleukin maintenance data show durable responses in moderate-to-severe atopic dermatitis